Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NHLH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SCNN1G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR90 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RHAG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUFU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IGLON5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102724718 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929356 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPKBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on